Throughout 2017, Life Science Washington will focus on smaller, personal engagements with legislators and policy makers.
To help us implement this more personal approach, please send us an email if you have a personal relationship with a member of the legislature so that we can include you in those conversations. Likewise, if you or your company would like to host a round-table discussion at your facility, please let us know and we will get in touch with you to coordinate the details. Life Science Washington will handle everything! You just need to do what you do best — show how your company is developing products that improve people’s lives!
Governor's Life Science & Global Health Advisory Council Report
Advisory Council Report (short version “Life Science and Global Health Development in Washington State: Future at Risk")
Drug Pricing is in the News; Here's What You Should Know
Recently, news and political discourse about the healthcare and pharmaceutical industry has been dominated by discussions about the cost of drugs. As we enter a Presidential election year, it is likely that drug costs and pricing will continue to be front and center. To address this issue, the Biotechnology Industry Association (BIO) drafted a white paper designed to help people better understand the innovative work we do and the risk that is undertaken to bring life-saving cures and innovative therapies to market. If you are interested in receiving the full white paper titled, “Unleashing the Next Generation of Biotechnology Innovation,” please email email@example.com